About the Staff

Prof. Eyal Fenig brings decades of top-tier clinical and academic experience in oncology. He serves as the Director of the Radiotherapy Unit at the Davidoff Comprehensive Cancer Center, Rabin Medical Center (Beilinson Campus), and as a Clinical Associate Professor at the Sackler Faculty of Medicine, Tel Aviv University.

Prof. Fenig graduated from the Technion Faculty of Medicine with honors (Cum Laude). He completed his residency in oncology at Beilinson, followed by fellowships and research work at world-leading cancer centers in the USA:

• Clinical and Research Fellow at the Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York (1992-1994).
• Observership at MD Anderson Cancer Center, Houston, Texas (1990-1991).

As part of his professional and academic work, Prof. Fenig is extensively involved in research, advanced treatments, and the integration of innovative technologies to improve treatment outcomes for cancer patients.

Iris Tamir holds a Master's degree in Life Sciences and Business Administration. Between 1996 and 2018, she worked in marketing and sales management at leading global pharmaceutical companies (Teva, AstraZeneca, Bayer) and managed diverse medical fields. In 2012, she launched a first-of-its-kind app for inhaler usage instruction.

Personal Vision: "The analogy that moves me most is the story of 'The Flower with the Golden Heart'... Just like the child who wants to cure his mother with the distant flower, a clinical trial can be the 'Golden Heart Flower' for a cancer patient. I am here to raise awareness of clinical trials and share their benefits."

Today, Iris leads business development and marketing at the company, having significantly increased collaborations with patient associations and medical entities.

Einav Bar is a certified Clinical Trials Manager with a Master's degree in Emergency and Disaster Management from the University of Haifa. She has accumulated extensive experience as a Clinical Research Coordinator in the Hematology Department at Ichilov and as a Research Assistant at Johnson & Johnson.

During 15 years of activity in biotech R&D, Einav led projects in synthetic biology and CRISPR which were presented to MIT and won a prestigious award for innovation.

She brings a combination of scientific expertise, creativity, and deep commitment to advancing high-quality, patient-centered medical research.

Mark serves as the European Account Manager at Trial-In Pharma. He is employed as a VP at EMAS and leads the company's strategic collaboration across the European continent.

He brings extensive experience in international business development, sales management, and strategy in global markets, specializing in building long-term relationships and cultural bridging for the benefit of patients.

Teva Erez is responsible for managing the company's information systems and implementing advanced automations to streamline workflows.

In his role, Teva ensures that the company's digital infrastructures operate smoothly and securely, developing technological solutions that allow the team to focus on patient care while reducing bureaucracy and manual work.

Dolev Erez manages the Artificial Intelligence (AI) domain at the company. He leads the implementation of the most innovative technologies to enhance the company's data analysis capabilities.

Dolev combines deep technological knowledge with business understanding, working to harness the power of AI to find more accurate and faster solutions for the company's clients.